alphaveINSECTICID₹614.00

Insecticides (India) Limited

Annual Quarterly₹ CrorePeersIPL MOL BHARATRAS PUNJABCHEM ASTEC GSPCROP DHARMAJ BHAGCHEMMcap ₹1,787 Cr

View

In ₹ Crore except Per Share 12 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	696.0	357.9	272.5	656.7	627.1	357.7	358.9	691.1	637.7	384.9	426.3	611.5
Other Income	-0.2	1.2	4.5	2.5	1.5	0.2	2.9	3.7	2.5	0.8	4.7	5.3
Total Income	695.8	359.2	277.0	659.2	628.6	357.9	361.8	694.8	640.2	385.7	431.0	616.9
Expenses
+ Cost of Materials Consumed	391.7	260.4	270.1	339.1	449.1	236.0	326.4	372.9	363.0	217.6	246.7	358.3
+ Purchases of Stock-in-Trade	67.5	39.4	7.7	21.0	21.0	21.0	12.2	45.1	57.8	15.1	51.6	107.0
+ Changes in Inventories	63.3	-49.8	-92.2	116.0	-41.4	-28.4	-111.0	71.5	-2.9	27.4	-0.8	-46.9
+ Employee Benefit Expense	34.1	27.7	25.8	38.8	38.5	32.5	28.6	41.5	47.8	36.5	38.0	47.3
+ Finance Costs	2.9	2.8	2.1	1.6	1.7	1.4	2.1	3.7	4.2	4.7	4.3	4.7
+ Depreciation & Amortisation	7.4	7.4	7.6	7.1	7.2	7.6	7.2	7.3	9.3	9.4	9.4	9.7
+ Other Expenses	57.5	54.2	52.1	70.2	70.4	65.8	74.2	75.5	82.5	61.0	65.3	78.2
Total Expenses	624.3	342.1	273.2	593.9	546.5	335.8	339.8	617.6	561.7	371.6	414.4	558.3
EBITDA	81.9	26.0	9.0	71.5	89.6	30.9	28.5	84.6	89.5	27.4	25.6	67.6
EBIT	74.6	18.6	1.4	64.4	82.3	23.3	21.3	77.3	80.1	18.0	16.2	57.9
Profit
PBT before Exceptional Items	71.5	17.0	3.8	65.3	82.1	22.1	22.0	77.3	78.5	14.1	16.6	58.5
+ Exceptional Items	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
Pretax Income	71.5	17.0	3.8	65.3	82.1	22.3	22.0	77.3	78.5	14.1	16.6	58.5
+ Current Tax	18.3	5.4	-1.5	17.2	20.9	5.4	12.3	18.7	19.8	4.3	1.0	16.5
+ Deferred Tax	0.3	-0.7	-2.5	-0.8	-0.0	-0.5	-4.1	0.6	-0.1	-0.5	3.3	-1.6
Tax Expense	18.6	4.8	-4.0	16.4	20.8	4.9	8.1	19.3	19.7	3.8	4.4	14.9
+ Share of Associates & JVs	0.2	0.0	-0.1	0.2	0.2	0.0	0.0	0.2	0.4	0.2	-0.5	0.3
Net Income	53.2	12.3	7.8	49.0	61.5	17.4	13.9	58.1	59.1	10.5	11.7	43.9
+ Net Income — Continuing Ops	53.0	12.3	7.8	48.8	61.3	17.4	13.9	57.9	58.8	10.2	12.2	43.6
+ Other Comprehensive Income	-1.2	0.1	1.4	-1.7	1.9	-0.7	-0.7	-0.1	1.4	-1.5	2.4	-1.6
Total Comprehensive Income	51.9	12.4	9.1	47.3	63.3	16.6	13.1	58.1	60.5	9.0	14.1	42.3
Net Income to Common	—	0.0	0.0	49.0	0.0	—	0.0	0.0	0.0	-1.5	11.7	43.9
Minority Interest	—	0.0	0.0	0.0	0.0	—	0.0	0.0	0.0	0.0	2.4	0.0
Per Share
Basic EPS	17.95	4.16	2.62	16.56	20.78	5.96	4.77	19.97	20.31	3.60	4.02	15.08
Diluted EPS	17.95	4.16	2.62	16.56	20.78	5.96	4.77	19.97	20.31	3.60	4.02	15.08
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	-0.7	-0.1	1.4	-1.5	2.4	-1.6
+ Items NOT to be Reclassified to P&L	-1.2	0.1	1.4	-1.7	1.8	-0.7	-0.7	-0.1	1.4	-1.5	2.4	-2.1
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.0	0.0	0.0	0.0	0.0	-0.5
+ Items to be Reclassified to P&L	—	—	—	-0.0	0.0	-0.0	0.0	-0.0	0.0	0.0	—	—
Comprehensive Income — Owners of Parent	0.0	0.0	0.0	1.7	0.0	16.6	0.0	0.0	1.4	9.0	14.1	42.3
Comprehensive Income — Non-controlling Interests	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	17.95	4.16	2.62	16.56	20.78	5.96	4.77	19.97	20.31	3.60	4.02	15.08
Diluted EPS — Continuing Operations	17.95	4.16	2.62	16.56	20.78	5.96	4.77	19.97	20.31	3.60	4.02	15.08
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	173.5	108.0	86.9	180.6	198.5	129.2	131.4	201.7	219.7	124.8	128.9	193.2
Gross Margin %	24.93	30.16	31.88	27.50	31.65	36.12	36.60	29.18	34.45	32.43	30.23	31.59
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	71.5	17.0	3.8	65.3	82.1	22.1	22.0	77.3	78.5	14.1	16.6	58.5
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
Net Income Adj (tax-effected)	53.2	12.3	7.8	49.0	61.5	17.2	13.9	58.1	59.1	10.5	11.7	43.9
EPS Adj	17.95	4.16	2.62	16.56	20.78	5.90	4.77	19.97	20.31	3.60	4.02	15.08
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	0.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	29.6	29.6	29.6	29.6	29.6	29.1	29.1	29.1	29.1	29.1	29.1	29.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.